Companion Animal

Elanco Receives FDA Approval for Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets), the Broadest(i) Canine Oral Parasiticide Protection in a Single Monthly Dose

Elanco Receives FDA Approval for Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets), the Broadest(i) Canine Oral Parasiticide Protection in a Single Monthly Dose

Source: PR Newswire Elanco Animal Health has announced FDA approval for Credelio Quattro™, a new monthly chewable tablet offering the broadest parasite protection for dogs. Credelio Quattro protects against six types of parasites: fleas, ticks, heartworms, and three... read more